News from indivior plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 29, 2020, 07:15 ET Indivior Announces Availability of Third Quarter and Nine Months 2020 Results

Indivior PLC (LON: INDV) today announced that financial results for the third quarter and nine months period ended September 30, 2020, including the...


Sep 24, 2020, 02:30 ET Indivior Takes Strategic Alignment Actions

Indivior PLC (LON: INDV) today announced that it is taking organizational and cost actions to better align its capabilities and resources with the...


Jul 30, 2020, 02:19 ET Indivior First Half and Second Quarter 2020 Results Now Available; Conference Call With Leadership Today

Indivior PLC (LON: INDV) today announced that its first half and second quarter 2020 results press release is now available via the London Stock...


Jul 24, 2020, 10:35 ET Indivior Announces Agreement to Resolve Criminal Charges and Civil Complaints Related to SUBOXONE® Film

Indivior PLC (LON: INDV) ("Indivior" or the "Company") announced that it has reached an agreement with the United States Department of Justice...


May 14, 2020, 07:37 ET Indivior Q1 2020 Results Now Available; Conference Call With Leadership Today

Indivior PLC (LON: INDV) today announced that its Q1 2020 press release is now available via the London Stock Exchange's Regulatory News Service...


Apr 16, 2020, 08:00 ET SUBLOCADE® Long-Term Safety Data Published in Journal of Clinical Psychopharmacology

Indivior PLC (LON: INDV) today announced the publication of long-term safety data for SUBLOCADE® (buprenorphine extended-release) injection, for...


Feb 13, 2020, 02:24 ET Indivior Full Year 2019 Results Now Available; Leadership Presentation Today

Indivior PLC (LON: INDV) today announced that its full year 2019 press release is now available via the London Stock Exchange's Regulatory News...


Dec 10, 2019, 09:30 ET Virginia Tech and Indivior Announce New Collaboration to Study Long-Term Recovery in People with Opioid Use Disorder

Indivior PLC (LON: INDV) today announced a new research collaboration with Virginia Tech extending the RECOVER (Remission from Chronic Opioid...


Dec 02, 2019, 08:00 ET New Analysis From One-Year Study of Monthly Buprenorphine Extended-Release Injections Showed Improved or Stable Patient-Centered Outcomes

Indivior PLC (LON: INDV) announced today that new analysis from a 12-month investigation of monthly buprenorphine extended-release injections showed...


Sep 26, 2019, 15:19 ET Announcement of National Institutes of Health (NIH) Grant Award through the NIH Helping to End Addiction Long-term (HEAL) Initiative

Indivior PLC (LON: INDV) announces that the National Institutes of Health (NIH) has granted Indivior's application entitled "Clinical Evaluation of...


Jul 11, 2019, 05:15 ET Indivior Raises FY 2019 Net Revenue and Net Income Guidance; Cash at H1 2019 Expected to be Approximately $985m

Indivior PLC (LON: INDV) today announced revised expectations for FY 2019 net revenue and net income following stronger than expected H1 2019 net...


May 02, 2019, 07:15 ET Indivior First Quarter 2019 Results Now Available; Conference Call With Leadership Today

Indivior PLC (LON: INDV) today announced that its first quarter 2019 press release and investor supplement are now available via the London Stock...


Apr 09, 2019, 18:01 ET Statement of Indivior on Grand Jury Indictment

Indivior PLC (LON: INDV) issued the following statement today in response to an indictment returned by a federal grand jury in the Western District...


Feb 27, 2019, 08:06 ET Indivior Announces Launch of PERSERIS™ (risperidone) for the Treatment of Schizophrenia in Adults

Indivior PLC (LON: INDV) today announced the launch of once-monthly PERSERIS™ (risperidone) for extended-release injectable suspension in the United...


Feb 20, 2019, 09:37 ET Indivior Announces Launch of SUBOXONE® (buprenorphine and naloxone) Sublingual Film Authorized Generic

Indivior PLC (LON: INDV) today announced that its U.S. affiliate, Indivior Inc., has launched an authorized generic version of SUBOXONE®...


Dec 18, 2018, 07:20 ET Indivior Provides Legal and Trading Update; Confirms Launch of PERSERIS™ and Key Elements of Contingency Plan

Indivior PLC (the "Company") with today's announcement and accompanying supplement published on its website (http://www.indivior.com) is: Providing...


Dec 12, 2018, 08:00 ET Court of Appeals for the Federal Circuit Declines to Immediately Issue Mandate After Preliminary Injunction Ruling

Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) has denied Dr....


Nov 27, 2018, 08:00 ET Indivior to Host Conference Call on December 18th; Previously-Scheduled Capital Markets Day to be Held in February 2019

Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that in light of the recent decision by the Court of Appeals for the Federal...


Nov 23, 2018, 09:56 ET Indivior Announces Health Canada Approval of SUBLOCADE™ (Buprenorphine Extended-Release) Injection for Patients with Moderate to Severe Opioid Use Disorder

Indivior PLC (LON: INDV) today announced that Health Canada has approved SUBLOCADETM (buprenorphine extended-release) injection for subcutaneous...


Nov 21, 2018, 09:30 ET Court of Appeals for the Federal Circuit Lifts Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film

Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated the...


Nov 19, 2018, 08:39 ET PERSERIS™, the First Once-Monthly Risperidone-Containing Subcutaneous Long-Acting Injectable, Now Available in the U.S. for the Treatment of Schizophrenia in Adults

Indivior PLC (LON: INDV) today announced that PERSERIS™ (risperidone) for extended-release injectable suspension is now available in the United...


Nov 06, 2018, 08:00 ET Indivior Announces Upcoming Investor Events

Indivior PLC (LON: INDV) today announced the following upcoming investor events: Stifel 2018 Healthcare Conference, New York City: On Tuesday,...


Nov 01, 2018, 07:26 ET Indivior Announces Nine Month and Third Quarter 2018 Results

Indivior PLC (LON: INDV) today announced that its financial results for the period ended September 30, 2018, including the earnings release and...


Sep 26, 2018, 11:57 ET Indivior Provides Update on Key Business Drivers and Expectations

Indivior PLC (LON: INDV) today is providing a further update on key business drivers and expectations related to: FY 2018 net revenue and net income...


Sep 12, 2018, 06:51 ET Indivior Unable to Participate in Morgan Stanley Healthcare Conference Due to Adverse Weather

Indivior PLC (LON: INDV) today announced that due to adverse weather expected from Hurricane Florence, the recently declared state of emergency in...